BillionToOne UNITY Screen's Unique Approach to Cystic Fibrosis Prenatal Screening Allows More Treatment Options for Expecting Families

Largest study of CF prenatal screening to date showed UNITY Fetal Risk™ Screen identifies all CF cases in study population

MENLO PARK, Calif. , Sept. 15, 2025 /PRNewswire/ -- BillionToOne , Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced a new publication demonstrating the superior performance of its UNITY Fetal Risk™ Screen in identifying fetuses at high risk for cystic fibrosis (CF). The comprehensive retrospective study, published in the peer-reviewed Journal of Cystic Fibrosis titled, Routine cell-free DNA prenatal screening identifies pregnancies at high risk for cystic fibrosis that may benefit from fetal therapy 1 , analyzed over 100,000 consecutive general-risk pregnant pati